BONESUPPORT
LIVE

Serial Number

87150877

Owner

BoneSupport AB

Attorney

Karen Kreider Gaunt

Filing Date

Aug 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

BONESUPPORT Trademark

Serial Number: 87150877 • Registration: 5592831

BONESUPPORT is a trademark filed by BoneSupport AB on August 25, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BoneSupport AB (4 trademarks)

Scheelevagen 19
Lund SE-22370 , SE

Entity Type: 09

Trademark Details

Filing Date

August 25, 2016

Registration Date

October 30, 2018

Published for Opposition

May 8, 2018

Goods & Services

Education, namely, provision of teaching and training in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; provision of teaching and training in relation to apparatus, instruments and equipment in connection with injectable bone substitute material; provision of teaching and training in relation to injectable bone substitute material; provision of teaching and training in relation to bone disease and the impact upon bones of various cancers; provision of teaching and training in relation to [ medicine, ] medical techniques, medical technical products and medical services; provision of teaching and training for medical and healthcare professionals in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; [ provision of teaching and training in relation to osteopathy; ] provision of teaching and training in relation to bone filling and implant services; advisory and consultancy services relating to the aforementioned

Injectable bone substitute material consisting of natural materials; injectable bone material consisting of natural materials for treatment of osteoporotic fractures; injectable bone filler consisting of natural materials for tissue generation; living tissue, cells and/or molecules produced in vitro for replacement and/or support of the function of missing or injured body parts; bone void fillers consisting of natural materials; [ bone fillers consisting of living materials; ] bone void fillers consisting of natural materials; [ bone growth media consisting of biological materials for medical purposes; pharmaceutical products and preparations for the treatment of bone diseases; ] pharmaceutical products and preparations for the treatment of bone fractures; injectable osteoconductive materials consisting of natural materials; injectable radiopaque bone substitute consisting of natural materials; natural bioceramic bone substitutes; bone remodelling materials consisting of natural materials; pharmaceutical preparations for use within [ general surgery, urology, odontology, ] orthopedic surgery *;* [ and cosmetic surgery; ] biological preparations for treatment of fractures, osteoporotic fractures, and bone voids caused by trauma, infection, disease or associated surgery; natural biomaterial for augmentation of bone and tissue for medical purposes; ceramics for medical purposes, namely ceramics for use within general surgery, urology, odontology, orthopedic surgery and cosmetic surgery; biological bone implant material

[ Medical imaging services; medical testing for diagnostic or treatment purposes; ] medical information; [ rental of medical equipment; leasing of medical equipment; medical screening; medical counselling; ] medical consultation; [ charitable services, namely, providing medical services; medical services for the treatment of bone cancer and tumours; medical services for the treatment of bone disease; medical services in connection with injectable bone substitute material; medical services in connection with injecting bone substitute material; diagnostic, medical and treatment services in connection with preparing bone substitute material and equipment therefor; ] advisory and consultancy services relating to the aforementioned

[ Hypodermic injectors; medication injectors; ] injection syringes; [ needles for syringes; ] injection device for pharmaceuticals; injectors for medical purposes; apparatus, instruments and equipment for preparing of injectable bone substitute material; apparatus, instruments and equipment for injecting injectable bone substitute material; bone substitutes for surgical use; substitutes for bones; non-biological bone implant material; artificial bone materials; artificial bone materials of ceramics; artificial bone parts to be implanted in natural bones; apparatus, instruments and equipment for preparing and application of pharmaceutical preparations for medical purposes; containers for bone substitutes; mixing instruments for medical purposes; injection instruments as well as instruments for preparing and making the injection easier; instruments and equipment for preparing and application of biological preparations for medical purposes; apparatus, instruments and equipment for preparing and application of biomaterials for medical purposes; apparatus, instruments and equipment for preparing and application of ceramic material for medical purposes; apparatus, instruments and equipment instruments for preparing and application of bone substitute material for medical purposes; apparatus, instruments and equipment instruments for preparing and application of preparations used in surgery, [ urology, odontology, ] orthopaedic [ , and cosmetic ] operations; artificial bone substitutes and bone expanders for odontological, [ cosmetically and ] operative procedures; parts and fittings for the aforementioned goods; biphasic injectable ceramic bone substitute

Scientific and technological services namely, scientific research, analysis, and testing, in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders and research and design relating thereto; [ medical and pharmacological research and development services; ] analysis of medical and technical research and development; industrial analysis and research services in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; clinical research in the field of the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; clinical trials [ for others ] relating to the development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders; conducting clinical trials and research in the field of bone disease; conducting clinical trials and research in the field of for injectable bone substitutes, materials and fillers; design and development of computer software in connection with injectable bone substitute material, injecting bone substitute material, preparing bone substitute material and equipment therefor; information, advisory and consultancy services relating to the aforementioned; development and commercialization of injectable bio-ceramic composites for patients suffering from bone disorders

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 19, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 19, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 19, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 11, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 30, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Sep 24, 2018 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 24, 2018 AITU
NOTICE OF ALLOWANCE CANCELLED
Sep 4, 2018 IUCN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 4, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 4, 2018 COAR
TEAS DELETE 1(B) BASIS RECEIVED
Sep 4, 2018 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 3, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2018 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2018 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2018 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 8, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 6, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 18, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jul 18, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jul 18, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2017 CRFA
ASSIGNED TO LIE
Jul 7, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 1, 2016 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2016 NWOS
NEW APPLICATION ENTERED
Aug 29, 2016 NWAP